Cargando…
Review of guidelines on the treatment of metastatic renal cell carcinoma
Guidelines on the management of metastatic renal cell carcinoma (rcc) have emerged over the last couple of years because of the introduction of effective new targeted therapies. However, current guidelines are not always contemporary because of older data whose relevance is unclear in the context of...
Autor principal: | Soulières, D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687806/ https://www.ncbi.nlm.nih.gov/pubmed/19478902 |
Ejemplares similares
-
State-of-the-art treatment of metastatic renal cell carcinoma
por: Heng, D.Y.C., et al.
Publicado: (2009) -
Sorafenib in the management of metastatic renal cell carcinoma
por: Guevremont, C., et al.
Publicado: (2009) -
Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
por: Schlemmer, Marcus, et al.
Publicado: (2019) -
Metastatic Renal Cell Carcinoma to the Scalp: A Case Report With Review of Literature
por: Meshikhes, Huda A, et al.
Publicado: (2023) -
Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era
por: Scheipner, Lukas, et al.
Publicado: (2023)